DanDi Bioscience

ENG

다국어페이지

ENG
KOR

DanDi Bioscience

KOR

NEWS

What’s new?

HOME
PR
NEWS
- Notice

No.	Title	Date
42	HLB Science Wins 4th Korea Venture Award for Excellence in Startup Patent Awards	2024-12-02
41	HLB Science Agrees With NordCure To Joint Microbiome Research	2024-12-02
40	HLB Science xxxselected health care technology research and development project	2024-12-02
39	"HLB Science Accelerates Clinical Trials for Sepsis..."Dream of collaborating with Big Pharma"	2024-12-02
38	HLB Science Recognizes 'Health Care R&D Excellence' for Sepsis New Drug Technology	2023-01-13
37	Will HLB Science's stock price rebound with the entry into phase 1 clinical trials for sepsis treatm	2023-01-13
36	HLB Science, KRP Report (Kiwoom Securities)	2023-01-13
35	HLB Science, research agreement with Theranochem to develop anti-cancer drugs	2023-01-13
34	HLB Science. Seeking cooperation for innovative sepsis treatment in 'Bio Europe'	2023-01-13
33	HLB Science presented a poster at the Korean Society for Molecular and Cellular Biology	2023-01-13

1
2
3
4
5

DanDi Bioscience

CEO of HLB Science Inc. : Jong-Sun Yoon Business license number : 677-88-00337 Ethical Management(Cyber Report)

CopyrightⓒHLB Science. ALL RIGHTS RESERVED